According to Insmed's latest financial reports the company's current EPS (TTM) is -$7.30. In 2022 the company made an earnings per share (EPS) of -$5.40 a decrease over its 2021 EPS that were of -$5.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$7.09 | 31.21% |
2022 | -$5.40 | 0.78% |
2021 | -$5.36 | 28.57% |
2020 | -$4.17 | -0.99% |
2019 | -$4.21 | -27.96% |
2018 | -$5.85 | 47.55% |
2017 | -$3.96 | 0.7% |
2016 | -$3.94 | 39.9% |
2015 | -$2.81 | 9.73% |
2014 | -$2.56 | 17.09% |
2013 | -$2.19 | 0.64% |
2012 | -$2.18 | -46.42% |
2011 | -$4.06 | 497.96% |
2010 | -$0.68 | -105.1% |
2009 | $13.32 | -850.78% |
2008 | -$1.77 | -24.71% |
2007 | -$2.36 | -71.67% |
2006 | -$8.31 | -28.57% |
2005 | -$11.64 | 23.53% |
2004 | -$9.42 | 134.48% |
2003 | -$4.02 | -73.64% |
2002 | -$15.24 | -2.65% |
2001 | -$15.66 | -86.64% |
2000 | -$117.24 |